SEC Form 4 · accession 0001225208-17-008904
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sanat Chattopadhyay
Officer — Exe V-P & Pres. MMD
Period of report
May 2, 2017
Accepted (ET)
May 3, 2017 · 9:54 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 2, 2017 | M | 3,092 | $0.00 | A | 43,637 | D | |
| Common StockF1 | May 2, 2017 | F | 974 | $62.38 | D | 42,663 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2 | — | May 2, 2017 | M | 3,092 | D | May 2, 2017 | May 2, 2017 | Common Stock | 3,092 | 0 | D |
Explanation of responses
- F1Holdings include shares acquired in dividend reinvestment transactions.
- F2Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.